Funds keep Archimedes Pharma buoyant
March 3, 2010Research and Development Archimedes, funding
Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …
Awareness push for dementia
March 3, 2010dementia, disease awareness campaigns
The government’s offensive on dementia has continued with a new awareness campaign called Living Well, which aims to break down …
UK hit hard as AstraZeneca reveals R&D cuts
March 3, 2010Research and Development AstraZeneca, job cuts
Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …
Adrian Kemsley joins Ogilvy Healthworld
March 3, 2010Medical Communications Ogilvy, appointment, medical communications, ogilvy healthworld advertising
Ogilvy Healthworld Advertising has appointed Adrian Kemsley as creative director and overall lead for the agency and unveiled a new …
Dr Olaf Stange to head up Bayer Technology in Singapore
March 3, 2010Manufacturing and Production Bayer Technology Services, appointment, manufacturing and production
Bayer has appointed Dr Olaf Stange to head up its new Southeast Asia regional office for Bayer Technology Services (BTS) …
Stability data issue holds up Adventrx cancer drug
March 3, 2010Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine
US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …
Digital Pharma: AZ outlines its online principles
March 2, 2010Medical Communications FDA, digital pharma, social media
AstraZeneca says it has an obligation to use social media to help empower patients and prescribers to make informed decisions …
Astellas moves in on OSI Pharmaceuticals
March 2, 2010Sales and Marketing Astellas, Astellas Pharma Europe, OSI
Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …
Warner Chilcott sees major jump in revenue
March 2, 2010P&G, Warner Chilcott
Warner Chilcott saw a big increase in 2009 revenue thanks to its acquisition of Proctor and Gamble’s branded pharmaceuticals business. …
Merck shows off expanded pipeline
March 2, 2010Sales and Marketing Merck, Schering-Plough
Merck has put its new pipeline on display for the first time since its October merger with Schering-Plough was completed. …
Shire launches Vpriv to capitalise on Genzyme woes
March 2, 2010Sales and Marketing Cerezyme, Gaucher's, Shire
Shire has gained US approval to launch Vpriv, its new treatment for Gaucher’s disease, which it hopes will steal market …
David White joins The Research Partnership
March 2, 2010Sales and Marketing The Research Partnership, appointment, sales and marketing
The Research Partnership has appointed David White director of syndicated services. Based in London, David will oversee the development and …
Kinex Pharmaceuticals appoints Rudolf Kwan
March 2, 2010Research and Development Kinex Pharmaceuticals, appointment, research and development
Dr Rudolf Kwan has joined Buffalo, US-based Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …
Clinical research news in brief
March 2, 2010Research and Development Community Research, Evotec, FDA, INC Research, Kendle, Parexel
A round-up of recent developments in the clinical research arena includes proposals from the FDA on reporting falsified trials, Kendle’s …
Quotient Bioresearch Presents Comprehensive Drug Development Capabilities via New Company Website
March 1, 2010Research and Development
Quotient Bioresearch partners its clients with a unique offering of leading-edge technologies and services for all stages of early drug …
Merck KGaA invests in bioresearch and bioproduction
March 1, 2010Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services
Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …
Single orphan document will simplify process for industry
March 1, 2010Research and Development EMA, FDA, Orphan
The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …
Emerging Markets: finding your way in a Brave New World
March 1, 2010Sales and Marketing Brazil, China, India, Russia, em, emerging markets, sales, sales force effectiveness
Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …
Kerrita McClaughlyn joins Hill & Knowlton
March 1, 2010Medical Communications Hill & Knowlton, appointment, medical communications
Hill & Knowlton International Belgium has appointed Kerrita McClaughlyn as an account manager in its healthcare communications team. In her …
ICON sees revenues rise in 2009
March 1, 2010Research and Development CRO, ICON
Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
